Skip to content
K = 0.731

Citrini and Anthropic Test Claude-Designed Proteins Against Scorpion Toxins

1 reports 1 reporting sources 3 hours agoNew

Understand the event

AI overview

Citrini Research and Anthropic tested protein designs generated by an unreleased version of Claude, finding that 17 bound to four of five targeted scorpion toxins, but the experiment did not produce an antivenom drug. Citrini sent the designs to two outside laboratories, Swiss biotech company Adaptyv Bio and US-based Twist Biosciences, to test whether the proteins bound to their intended targets. Binding is a step toward developing antivenom, but it does not establish that the proteins neutralize toxins or could become safe, effective treatments. Researchers told The Verge that turning the promising results into medicine remains a long, challenging process.

Generated by AI from reports · Updated 1 hours ago

Latest development10/22 20:21 (UTC+8)
Claude Did Not Create a Scorpion AntivenomThe Verge · AI

Read next

More changes in today’s briefingMicrosoft Research and Collaborator Resolve the KLS Conjecture With Human-Directed AI

Report timeline

Follow the reports to explore different sides of the event.

10/22
  1. The Verge · AI
    Claude Did Not Create a Scorpion Antivenom

    Citrini Research and Anthropic tested whether an unreleased version of Claude could help create scorpion antivenom, but the experiment did not produce a drug. Claude generated protein designs, and 17 bound to four of the five targeted toxins; binding does not show that they neutralize toxins or can become safe, effective treatments. Researchers told The Verge that turning the promising results into medicine remains a long, challenging process.

Keep up with AI, one email a day

Model releases, price changes and compute developments, with original sources. Free, confirmed by email, and easy to unsubscribe. Read a past issue

Event heat trend

There is not enough continuous observation data to plot a trend yet.